2019 impact NOW! report
REGISTER
biomedical HIV prevention
summit December 3-4, 2019 | Houston, TX Marriott Marquis Houston www.biomedicalhivsummit.org #2019BHPS
ABOUT THE SUMMIT The fourth annual Biomedical HIV Prevention Summit was held in Houston, Texas,
Dec. 3-4 2019. The response to this year’s Summit showed the growing importance of biomedical prevention in the fight against HIV and also the new federal plan to End the Epidemic. More than 1,400 people from around the nation came to Houston for the Summit, demonstrating the sustained need for this conference, particularly as plans to End the Epidemic are developed and implemented. The turnout also shows the ongoing importance of the Summit in the future.
Format The Summit centers on four plenaries for all conference attendees that explore major issues in greater detail. Unlike USCA, Summit plenaries are held in the round to create a greater sense of intimacy in the space. This year, the Summit offered more than 40 workshops covering a variety of topics related to biomedical prevention and its use by communities at risk. The 2019 Summit was the third year for the popular “Community Corner” sessions. These 15-minute presentations scheduled in-between workshops provided additional opportunities for education on a variety of biomedical prevention topics.
2
2019 BIOMEDICAL HIV PREVENTION SUMMIT
OPENING RECEPTION Welcome Reception The Summit Host Committee held a welcome reception at the pool deck of the Houston Marriott Marquis, the Summit host hotel. Featuring live performances to reflect the diversity of Houston, the reception was an opportunity to mingle in a casual setting.
2019 BIOMEDICAL HIV PREVENTION SUMMIT
3
PLENARIES There were four plenaries held during the Summit. The Summit’s opening plenary, “Biomedical HIV Prevention Research and Women,” delved into the importance of biomedical HIV prevention for women and why there are gaps in research and use of such tools by women. It also featured a tribute for trans lives lost to violence in 2019.
Ken Williams, plenary host
Houston Mayor Sylvester Turner
Plenary panel (Leisha McKinleyBeach, Danielle M. Campbell, Dr. Charlene Flash, Dr. Tosha Rogers, and Brittany Williams)
Honoring transgender lives lost to violence
4
2019 BIOMEDICAL HIV PREVENTION SUMMIT
PLENARIES “The Federal Plan to End the HIV Epidemic and the Role of Implementation Research” looked at the fundamentals of implementation science as it relates to the execution of engagement and retention strategies for people living with HIV and those at risk of infection that can benefit from biomedical HIV prevention modalities.
Harold J. Phillips, Senior HIV Advisor and Chief Operating Officer of Ending the HIV Epidemic: A Plan for America
(Above) David Purcell, JD, PhD, Deputy Director for Behavioral and Social Science, DHAP, Centers for Disease Control and Prevention (Right) Jhetari Carney, MPH, Health Resources and Services Administration
Captain Timothy Holtz, MD, MPH, Deputy Director, NIH Office of AIDS Research
Neeraj Gandotra, MD, Chief Medical Officer, SAMHSA
2019 BIOMEDICAL HIV PREVENTION SUMMIT
5
PLENARIES “Long Acting Injectables and the MOSAICO Vaccine Study: The New Paradigm on Biomedical HIV Prevention,” Wednesday’s breakfast plenary, discussed new HIV prevention modalities under study, including long acting injectables.
Ken Williams asks attendees about their thoughts on injectables and implants to prevent HIV
(Above) Sheldon D. Fields, PhD, The SDF Group, LLC Innovation Consultants
(Right) Ken Williams and Stephaun E. Wallace, PhD, MS, MOL, HIV Vaccine Trials Network
The Summit’s Closing Plenary, “HIV Criminalization and Biomedical HIV Prevention,” focused on how currently available biomedical HIV prevention techniques are being used to support the modernization of HIV Criminalization statutes.
NMAC Executive Director Paul Kawata speaks
(L to R) Nikko Briteramos, Los Angeles, CA; Kamaria Laffrey, HIV Consultant, Winter Haven, FL; Scott A. Schoettes, Lambda Legal, Chicago, IL; and moderator Ace Robinson, Director of Strategic Partnerships at NMAC
The Houston Host Committee closes the 2019 Summit
6
2019 BIOMEDICAL HIV PREVENTION SUMMIT
EXHIBITORS
Table Company
Table Company
1:
Gilead
18:
Express Med
2:
AIDSVu
19:
Abbott
3:
CCN Pharmacy
20: Help Center for LGBT Health and Wellness
4:
Curant Health
21:
5:
CAPTC
22: Health HIV
6:
Until There’s A Cure Foundation
23: RDE Systems
7:
ViiV
24: Janssen
8:
Texas Action Health
25: Chembio Diagnostics Center
9:
Say it with a Condom
26: In the Meantime Men’s Group
San Francisco Department of Public Health
10: Avita
27: Texas State Department of Health
11:
Multicultural AIDS Coalition
28: Pharm Blue
12:
Capacity for Health
29: FC2 Internal Condom
13:
Walgreens
30: B Holding Group
14:
Please Prepare Me
31:
15:
Healthvana
32: Bowtie Movement
16:
Prevention Access Campaign
33: Biolytical Laboratories
17:
Nurx
34: Host Committee
R&S Northeast
2019 BIOMEDICAL HIV PREVENTION SUMMIT
7
ATTENDANCE 2019 BHPS Attendance by Age Range*
2019 BHPS Attendance by Ethnicity*
8 2019 BIOMEDICAL HIV PREVENTION SUMMIT
ATTENDANCE 2019 BHPS Attendance by Gender Identity
2019 BHPS Attendance by HIV Status
2019 BIOMEDICAL HIV PREVENTION SUMMIT
9
ATTENDANCE
2019 BHPS Attendance by Sexuality
Mobile App Performance
885 Users
Total number of unique users across devices
10
780 Total
Logged In Users
83.8K 8.41K 30.3K 22K All User Minutes Navigation Engagement
Total number of actions across all users taken with the app (i.e., sessions, speakers, exhibitors… etc.)
2019 BIOMEDICAL HIV PREVENTION SUMMIT
Contributors Total number of attendee messages and social shares
Open
Total time spent in minutes, users used the app
Icon Taps
Total number of taps for all navigation icons
QUANTITATIVE DATA
2019 BIOMEDICAL HIV PREVENTION SUMMIT 11
QUANTITATIVE DATA
12
2019 BIOMEDICAL HIV PREVENTION SUMMIT
QUANTITATIVE DATA
2019 BIOMEDICAL HIV PREVENTION SUMMIT
13
QUANTITATIVE DATA
14
2019 BIOMEDICAL HIV PREVENTION SUMMIT
QUANTITATIVE DATA
2019 BIOMEDICAL HIV PREVENTION SUMMIT
15
QUANTITATIVE DATA
16
2019 BIOMEDICAL HIV PREVENTION SUMMIT
QUANTITATIVE DATA Quotes & Affirmations
“The Biomedical HIV Prevention Summit was the best conference for me as a peer and executive officer in this HIV public health work. I enjoyed it from start to finish.” - Jermaine Mondell, Greensboro, NC
Everything its the best conference ever i loved the conversations on sisters of color ive never walked away inspired before.
“One thing that this week’s Biomedical HIV Prevention Summit demonstrated was how critical it is that we fully integrate Community into all aspects of the work if we are ever to End the Epidemic! The science is amazing but even the research requires full participation of community to have results that are relevant.” - Christopher Hucks-Ortiz
Extremely well organized and run conference. Conference staff were super helpful and kind. The venue seemed perfect in regards to space, conference rooms, hotel rooms, and great food. The conference contained very relevant, educational information, and tools with knowledgeable speakers.
Overall summit theme, especially the opening plenary: my favorite as it validated my knowledge and WILL to do all I can to hear the voice, be the voice, and apply what I feel is my innate ability to encourage Black Women, and others to be their authentic selves and contribute in whatever manner they are gifted to help End HIV as an Epidemic in Texas, and beyond. As a Black woman w/ AIDS for 35yrs, I am determined to do even more via my vast networks-RWPC, DHTF Stigma Group, FastTrack,CABs etc
“Attending the Biomedical HIV Prevention Summit was simply life changing…I’m empowered, I’m inspired, and I’m looking forward to this path that God has created just for me.” - Chase Edward Hale
The fact that cisgender black women were (finally) given a seat at the table surrounding the discussion on ending the HIV epidemic, instead of just MSM—it was important that the conference reinforced that PrEP is for everyone.
I really loved the plenaries. Every plenary speaker was amazing! I loved the app use. Everything was ok n the app and made everything so easy to schedule, know where to go, and the interaction.
The phenomenal sessions that’s ranged pretty dramatically in terms of topics. I also liked the focus on Cis women of color in particular black cis women and increase the uptake of PrEP in this community given current uptake is so low
2019 BIOMEDICAL HIV PREVENTION SUMMIT
17
NMAC BOARD & STAFF STAFF Executive Office Paul Akio Kawata, Executive Director Kim Ferrell, Director of Operations
Development Robert York, Director of Development Diane Ferguson, Development Associate
Conferences Tara Barnes-Darby, Director of Conferences Alison J. McKeithen, Conferences Manager Shanta’ Gray, Conferences and Registration Coordinator Terrell Parker, Associate Program Manager Gabriella Spencer, Program Associate Communications Chip Lewis, Director of Communications
NMAC Training Center to End the Epidemic Ace Robinson, Director of Strategic Partnerships Charles Shazor Jr., Program Coordinator Treatment Moisés Agosto-Rosario, Director of Treatment Joanna Lopez, Associate Program Manager Government Relations Joe Huang-Racalto, Director of Government Relations & Public Policy
Finance and Administrative Division Bis Dhar, Director Ron Dorsey, Consultant
BOARD OF DIRECTORS Chair John W. Hill, Jr., Washington, DC Co-Chair Lance Toma, San Francisco Community Health Center, San Francisco, CA
Secretary Therese Rodriguez, Asian Pacific Islander Coalition on HIV/AIDS, New York, NY
Treasurer Valerie Rochester, AIDS United, Washington, DC
BOARD MEMBERS Oscar De La O Bienestar Human Services Los Angeles, CA Brenda Hunt Borderbelt AIDS Resource Team (BART) Lumberton, NC Monica Johnson HEROES - Helping Everyone Receive Ongoing Effective Support Columbia, LA Kelsey Louie, MSW, MBA Gay Men’s Health Crisis (GMHC) New York, NY Norm Nickens San Francisco Employees’ Retirement System San Francisco, CA Leonardo Ramon Ortega, MD, MPH Shalom Health Care Center, Inc. Indianapolis, IN
18
2019 BIOMEDICAL HIV PREVENTION SUMMIT
Mario Perez County of Los Angeles Department of Public Health Office of AIDS Programs & Policy Los Angeles, CA Rev. Ed Sanders Metropolitan Interdenominational Church Nashville, TN Evelyn Ullah Broward County, FL Rodolfo R. Vega JSI Research & Training Institute, Inc. Boston, MA Carlos E. Rodríguez-Díaz, PhD, MPHE, MCHES DC CFAR Milken Institute School of Public Health, George Washington University Washington, DC
THANK YOU TO OUR SPONSORS PRESENTING
BENEFACTOR
SUPPORTER
ALLY
2019 BIOMEDICAL HIV PREVENTION SUMMIT
19